BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1183054)

  • 1. False rise of starch-iodine determined amylase values caused by heparin treatment during haemodialysis.
    Pasternack A; Stenman UH
    Clin Chim Acta; 1975 Dec; 65(2):213-21. PubMed ID: 1183054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between starch and lipoprotein components.
    Pasternack A; Stenman UH; Kallio S; Solakivi-Jaakkola T; Helenius J
    Clin Chim Acta; 1983 Mar; 128(2-3):387-94. PubMed ID: 6189645
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis.
    Vaziri ND; Chang D; Malekpour A; Radaht S
    Am J Gastroenterol; 1988 Apr; 83(4):410-2. PubMed ID: 2450453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroamylasaemia after treatment with hydroxyethyl starch.
    Köhler H; Kirch W; Weihrauch TR; Prellwitz W; Horstmann HJ
    Eur J Clin Invest; 1977 Jun; 7(3):205-11. PubMed ID: 70354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of heparin on the lipid level during hemodialysis].
    Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
    Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum lipase and amylase levels in chronic renal failure: interpretation of results--effects of extrarenal purification].
    Thierry FX; Dueymes JM; Vernier I; Fauvel J; Meeus F; Meurisse JJ; Pene C; Conte JJ
    Nephrologie; 1988; 9(6):263-7. PubMed ID: 2467218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of several factors that intervene in hemodialysis on serum levels of triglycerides and free fatty acids.
    Pérez-García A; Bretó M; Alvarińo J; Alegre B; Cruz JM
    Clin Nephrol; 1979 Jul; 12(1):14-7. PubMed ID: 477051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids and lipoproteins in acute renal failure.
    Mydlík M; Ahlers I; Derzsiová K; Takác M
    Proc Eur Dial Transplant Assoc; 1976; 12():389-96. PubMed ID: 180523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with the amyloclastic determination of serum amylase.
    Carter JW; Staples WG; Simson E
    Clin Chem; 1973 Jun; 19(6):686-7. PubMed ID: 4705182
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of thiocyanate ions on starch-iodine reaction used for the estimation of alpha-amylase activity.
    Lathia D; Brendebach M
    Clin Chim Acta; 1978 Jan; 82(3):209-14. PubMed ID: 23226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia. A metabolic consequence of chronic renal failure.
    Bagdade JD; Porte D; Bierman EL
    N Engl J Med; 1968 Jul; 279(4):181-5. PubMed ID: 5658679
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal fat metabolism in chronic renal failure.
    Romics L; Makó J
    Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis.
    Matsui N; Nakagawa S; Sasaoka T; Suenaga M; Yoshiyama N; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1979; 16():135-40. PubMed ID: 121458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat inhibition of in vitro lipolysis and 14C ibuprofen protein binding in plasma from heparinized uraemic subjects.
    Pearce GA; Brown KF
    Life Sci; 1983 Oct; 33(15):1457-66. PubMed ID: 6621250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia in patients with chronic renal insufficiency.
    McCosh EJ; Solangi K; Rivers JM; Goodman A
    Am J Clin Nutr; 1975 Sep; 28(9):1036-43. PubMed ID: 1163470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of haemodialysis on lipase activity.
    Montalto G; Soresi M; Carroccio A; Galione A; Lorello D; Di Martino D; Cartabellotta A; Notarbartolo A
    Eur J Clin Chem Clin Biochem; 1997 Mar; 35(3):237-8. PubMed ID: 9127746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferences with the starch-iodine assay for serum amylase activity, and effects of hyperlipemia.
    Gitlitz PH; Frings CS
    Clin Chem; 1976 Dec; 22(12):2006-9. PubMed ID: 1000798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of prostacyclin infusion on haemodialysis efficiency and blood cells.
    Kuźniewski M; Sułowicz W
    Int Urol Nephrol; 1992; 24(5):555-63. PubMed ID: 1459834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.